For nearly 30 years, Mary Bartlett Bunge, Ph.D., worked tirelessly as a neuroscientist with The Miami Project to Cure Paralysis at the University of Miami Miller School of Medicine. Her pioneering work in the area of nervous system regeneration and her decades-long dedication to finding ways to repair spinal cord damage earned Bunge the 2018 Lifetime Achievement Award from the Greater Miami Chamber of Commerce.

The University of Miami Miller School of Medicine’s Department of Otolaryngology–Head and Neck Surgery is one of eight otolaryngology training programs in the U.S. to receive the Ruth L. Kirschstein National Research Service Award Institutional Research Training Grant (T32) for interdisciplinary research training in otolaryngology.

A new biotechnology startup with its origins in the work of two neuroscientists is capturing attention for its potential to revolutionize drug discovery at the University of Miami Miller School of Medicine. Truvitech’s patent-pending technology uses a unique combination of biochemical profiling, cell-based screening, and machine learning to rapidly discover responsive pharmacological targets.

Researchers at Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine have discovered a peripheral biomarker in human blood serum that can be used to detect the presence and progress of glioblastoma brain tumors before and after treatment.

A team of neurosurgeons and neurologists at UHealth – the University of Miami Health System has successfully treated a Central Florida man with Parkinson’s disease using a new implantable deep brain stimulation device. The team was the first in South Florida and among the first in the country to implant the Vercise DBS technology.